Location
United States, North America
Check Size
$100K - $5M
Investment Stage
Focus Areas
About Investor
Henry Brem is a Venture Partner at Catalio Capital, where he focuses on investments in BioTech and Drug Delivery companies at Seed and Series A stages with an investment range of $100K - $5.0M. Brem is the Harvey Cushing Professor and Director of the Department of Neurosurgery at Johns Hopkins Medicine, with joint appointments in oncology, ophthalmology, and biomedical engineering. He has extensive experience in biomedical research and is a co-founder of Focal Inc (acquired by Genzyme). Brem was elected to the National Academy of Medicine in 2003 and has received numerous awards including the Grass Foundation Award and Castle Connolly National Physician of the Year Award. He is based in Baltimore, Maryland and leverages his deep medical expertise to evaluate biotech investments for Catalio Capital.
Similar Investors
Abdul Ly
Seed
,Series A
,Paul Straub
Pre Seed
,Seed
,Shaun Abrahamson
Pre Seed
,Seed
,Riley Florsheim
Pre Seed
,Seed
,Steve Brownlie
Pre Seed
,Seed
,Danielle Graham
Pre Seed
,Seed
,Is this You?
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP